“…Both syndromes have overlapping phenotypic manifestations, including cardiovascular anomalies, calcium dysregulation, cognitive deficits and high rates of psychiatric comorbidities (Campbell et al, 2009). As a group, individuals with neurodevelopmental disabilities (e.g., 22q11DS, WS, fragile X, or Turner syndrome) have higher rates of neuropsychiatric, cognitive and social-behavioral deficits including nonverbal learning disorder, visuospatial deficits, attention deficit/hyperactivity disorder (ADHD), anxiety disorders and affective disorders, compared to typically developing (TD) individuals (Schneider et al, 2014; Siegel and Smith, 2011; Weisman et al, 2015; Zarchi et al, 2014). Additionally, individuals with 22q11.2DS have a 30-fold increased risk of developing psychosis compared to TD individuals and individuals with other neurodevelopmental disabilities (10-fold) (Schneider et al, 2014).…”